Dr. Parham Safaie Semnani, MD

Dr. Safaie Semnani practices at Milford Gastroenterology Associates Inc. in Milford, Massachusetts.

Dr. Safaie Semnani's NPI, 1205099546, was assigned on July 7, 2008. Dr. Safaie Semnani holds Ohio license 35-122329.

Dr. Safaie Semnani's primary practice is Milford Gastroenterology Associates Inc., at 215 West St, Milford, MA 01757 in Worcester County. The practice phone is (508) 478-6363.

Dr. Safaie Semnani's primary practice is Milford Gastroenterology Associates Inc. in Milford, Massachusetts. Dr. Safaie Semnani is also affiliated with UMass Memorial Health - Milford Regional Medical Center. The medical group on file is UMass Memorial Medical Group. Dmand AI also links Dr. Safaie Semnani to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Safaie Semnani practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Safaie Semnani's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Safaie Semnani is licensed in Ohio.

CMS data shows 1,029 Medicare services from Dr. Safaie Semnani across 13 procedure codes in 2024, for 517 Medicare patients. Medicare paid $89,484 for them.

CMS counts 517 Medicare patients who saw Dr. Safaie Semnani in 2024. The largest group is 75 to 84, with 183 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Safaie Semnani's median patient age at 65, with 55% women.

In 2024, Dr. Safaie Semnani wrote 807 Medicare Part D claims for 184 patients. 79% of them were for generic drugs. CMS names the drug for 615 of them, across 16 drugs with 11 or more claims each, at $292,948 in total drug cost. In 2023, CMS named 558 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Safaie Semnani for performance year 2024, reported as part of a group. Dr. Safaie Semnani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 165 procedures of colonoscopy by Dr. Safaie Semnani, more than 90% of the clinicians it reports for that procedure.

CMS Open Payments shows 398 general payments to Dr. Safaie Semnani from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $3,021.